BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27088512)

  • 1. Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1.
    Li Y; Luo S; Dong W; Song X; Zhou H; Zhao L; Jia L
    Lab Invest; 2016 Jul; 96(7):731-40. PubMed ID: 27088512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-2,8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K/Akt Pathway in Human Chronic Myeloid Leukemia.
    Zhang X; Dong W; Zhou H; Li H; Wang N; Miao X; Jia L
    IUBMB Life; 2015 Feb; 67(2):77-87. PubMed ID: 25855199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression.
    Zhou H; Li Y; Liu B; Shan Y; Li Y; Zhao L; Su Z; Jia L
    Gene; 2017 Aug; 626():106-118. PubMed ID: 28512058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
    Han Y; Ma Z
    Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.
    Li Y; Zhao L; Li N; Miao Y; Zhou H; Jia L
    Oncol Rep; 2017 Apr; 37(4):2193-2200. PubMed ID: 28260112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
    Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
    Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D; Yang W; Zeng Y; Li W; Wang K; Zhao L; Li J; Ye Y; Guo Q
    Cell Signal; 2021 Aug; 84():110038. PubMed ID: 33984486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
    Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
    J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L; Shan Y; Liu B; Li Y; Jia L
    Cell Death Dis; 2017 May; 8(5):e2830. PubMed ID: 28542127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
    Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
    Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
    Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
    Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis.
    Dai H; Wang J; Huang Z; Zhang H; Wang X; Li Q; Feng W
    Technol Cancer Res Treat; 2021; 20():15330338211052150. PubMed ID: 34723728
    [No Abstract]   [Full Text] [Related]  

  • 15. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
    Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
    J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors.
    Nishioka C; Ikezoe T; Yang J; Nobumoto A; Tsuda M; Yokoyama A
    Cancer Sci; 2014 Mar; 105(3):297-307. PubMed ID: 24350829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
    Nie ZY; Liu XJ; Zhan Y; Liu MH; Zhang XY; Li ZY; Lu YQ; Luo JM; Yang L
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5.
    Jiang X; Cheng Y; Hu C; Zhang A; Ren Y; Xu X
    Leuk Lymphoma; 2019 Jul; 60(7):1709-1720. PubMed ID: 30516071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1.
    Ma H; Cheng L; Hao K; Li Y; Song X; Zhou H; Jia L
    PLoS One; 2014; 9(1):e85113. PubMed ID: 24454800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of
    Deng Y; Li X; Feng J; Zhang X
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.